LAURA HARPER: Open Payments
NPI 1760805444 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 21 payments from 10 companies in 2025. Trend: 2023 $161 · 2024 $0 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $247 |
| Gilead Sciences, Inc. | 6 | $201 |
| PFIZER INC. | 1 | $122 |
| Merck Sharp & Dohme LLC | 2 | $62 |
| ViiV Healthcare Company | 2 | $46 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Braeburn Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Indivior Inc. | 1 | $14 |
Products named: Ozempic, NURTEC ODT, Yeztugo, Rybelsus, PIFELTRO, Wegovy, APRETUDE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across CA — which companies pay providers there.
